ICON Public Limited Company (ICLR)
$
130.28
-0.79 (-0.61%)
Key metrics
Financial statements
Free cash flow per share
12.9127
Market cap
10.3 Billion
Price to sales ratio
1.2518
Debt to equity
0.3746
Current ratio
1.2702
Income quality
1.6165
Average inventory
0
ROE
0.0790
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services across Ireland, Europe, the United States, and globally. The company reported a substantial revenue of $8,281,676,000.00 reflecting its strong market presence. With a focus on the strategic development, management, and analysis of clinical programs, ICON supports various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. The company recorded an operating income of $1,097,812,000.00 reflecting its earnings from core operations, while the total costs and expenses for the company are $7,183,864,000.00 reflecting its overall spending. Additionally, the company reported selling, general, and administrative expenses of $728,348,000.00 indicating its operational overhead costs. Its clinical development services encompass a wide range of offerings, including early development, patient recruitment and retention, strategy and analytics, late phase research, and comprehensive data and technology solutions. Furthermore, it provides consulting and analytics services, medical imaging, clinical research and laboratory services, project management, site monitoring, data management, biostatistics, medical writing and publishing, and pharmacovigilance, tailored to meet the needs of pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company recorded a net income of $791,474,000.00 reflecting its profitability, illustrating its effectiveness in serving clients since its incorporation in 1990, with headquarters in Dublin, Ireland. Currently, the stock is priced at $131.07 positioning it in the higher-end market, indicative of strong investor interest. The stock has a high average trading volume of 1,475,879.00 indicating strong liquidity and investor confidence in the company's performance. With a mid-range market capitalization of $10,521,008,932.00 the company is a steady performer within the industry. As a key player in the Medical - Diagnostics & Research industry, ICON contributes significantly to the overall market landscape, driving innovation and growth within this critical sector. It belongs to the Healthcare sector, which emphasizes the importance of clinical research in advancing healthcare outcomes and enhancing patient care globally.
Is ICON Public Limited Company (ICLR) a good investment?
Investing in ICON Public Limited Company (ICLR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
What is ICON Public Limited Company (ICLR)'s stock forecast?
Analysts predict ICON Public Limited Company stock to fluctuate between $125.10 (low) and $347.72 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is ICON Public Limited Company's market capitalization?
As of 2025-05-30, ICON Public Limited Company's market cap is $10,521,008,932, based on 80,756,900 outstanding shares.
How does ICON Public Limited Company compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., ICON Public Limited Company has a Lower Market-Cap, indicating a difference in performance.
How can I buy ICON Public Limited Company (ICLR) stock?
To buy ICON Public Limited Company (ICLR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ICLR. Place an order (Market, Limit, etc.).
What is the best time to invest in ICON Public Limited Company?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has ICON Public Limited Company stock ever split?
ICON Public Limited Company's last stock split was 2:1 on 2008-08-13.
How did ICON Public Limited Company perform in the last earnings report?
Revenue: $8,281,676,000 | EPS: $9.60 | Growth: 28.69%.
Where can I find ICON Public Limited Company's investor relations reports?
Visit https://www.iconplc.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for ICON Public Limited Company?
You can explore historical data from here
What is the all-time high and low for ICON Public Limited Company stock?
All-time high: $347.72 (2024-07-16) | All-time low: $125.10 (2025-05-23).
What are the key trends affecting ICON Public Limited Company stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
prnewswire.com
LOS ANGELES , May 28, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
businesswire.com
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at the William Blair 45th Annual Growth Stock Conference.
prnewswire.com
LOS ANGELES , May 23, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
businesswire.com
DUBLIN--(BUSINESS WIRE)--ICON releases its ICON Cares 2024 Report.
seekingalpha.com
ICON Public Limited Company (NASDAQ:ICLR ) Q1 2025 Earnings Call Transcript May 1, 2025 8:00 AM ET Company Participants Kate Haven - Vice President, Investor Relations Steve Cutler - Chief Executive Officer Nigel Clerkin - Chief Financial Officer Barry Balfe - Chief Operating Officer Conference Call Participants Ahmed Muhammad - Leerink Partners Patrick Donnelly - Citi David Windley - Jefferies Justin Bowers - Deutsche Bank Jack Meehan - Nephron Research Jailendra Singh - Truist Securities Max Smock - William Blair Dan Leonard - UBS Michael Ryskin - Bank of America Luke Sergott - Barclays Matt Sykes - Goldman Sachs Eric Caldwell - Baird Charles Rhyee - TD Cowen Casey Woodring - JPMorgan Josh Waldman - Cleveland Research Operator Good day and thank you for standing by. Welcome to the ICON plc Q1 2025 Earnings Conference Call.
zacks.com
Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago.
prnewswire.com
LOS ANGELES , April 29, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
247wallst.com
The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift in the market landscape, with the S&P 500 now in correction territory.
prnewswire.com
LOS ANGELES , April 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 2, 2025.
accessnewswire.com
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=142601&wire=1 or contact Joseph E. Levi, Esq.
See all news
